Naphtalene derivatives and their pharmaceutical use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S317000, C514S345000, C546S001000, C546S192000, C546S301000

Reexamination Certificate

active

06846830

ABSTRACT:
Use of compounds of the formula (I) where A, E, R1, R2, p and q have the meanings given in the specification are GluR6 antagonists useful for the treatment of disorders of the central nervous system.

REFERENCES:
Clark et al, European Journal of Pharmacology, vol. 27, pp. 34-39, 1974.*
Waters et al, Journal of Medicinal Chemistry, vol. 29, pp. 1512-1561, 1986.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Naphtalene derivatives and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Naphtalene derivatives and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphtalene derivatives and their pharmaceutical use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3430830

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.